ExozymesEXOZ
13F holders, Q1 2025 (March 31)6holders −1
1new positions
2sold out
$10.45avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding Exozymes Inc. (EXOZ) in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($526K), Geode Capital Management, LLC ($215K) and BlackRock, Inc. ($47K).
- Company
- Exozymes Inc.
- CUSIP
- 461874109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $47K |
| Exits | 2 | $491K |
All 13F filers, Q4 2024 → Q1 2025: 9,066 shares bought and 30,399 shares sold, net −21,333 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Vanguard Group Inc. | 0.00% | Reduce -0.2% | 50,370 | $526K |
| Geode Capital Management, LLC | 0.00% | Add +22.9% | 20,596 | $215K |
| BlackRock, Inc. | 0.00% | New | 4,474 | $47K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +191.3% | 1,133 | $12K |
| UBS Group AG | 0.00% | Reduce -76.9% | 163 | $2K |
| Bank of America Corp. | 0.00% | Add +106.7% | 31 | $324 |
"% of holder's portfolio" is EXOZ's weight in each manager's 13F, not the share of Exozymes Inc. the manager owns.